MET: a promising anticancer therapeutic target.

Nature Reviews. Clinical Oncology
Solange Peters, Alex A Adjei

Abstract

The MET pathway is dysregulated in many human cancers and promotes tumour growth, invasion and dissemination. Abnormalities in MET signalling have been reported to correlate with poor clinical outcomes and drug resistance in patients with cancer. Thus, MET has emerged as an attractive target for cancer therapy. Several MET inhibitors have been introduced into the clinic, and are currently in all phases of clinical trials. In general, initial results from these studies indicate only a modest benefit in unselected populations. In this Review, we discuss current challenges in developing MET inhibitors--including identification of predictive biomarkers--as well as the most-efficient ways to combine these drugs with other targeted agents or with classic chemotherapy or radiotherapy.

References

Nov 30, 1992·Biochemical and Biophysical Research Communications·H KuniyasuE Tahara
Jul 1, 1995·The Journal of Urology·L L PistersL W Chung
Jul 17, 1996·International Journal of Cancer. Journal International Du Cancer·E M RosenI D Goldberg
Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T UekiE Okamoto
Apr 4, 1997·Science·G K Michalopoulos, M C DeFrances
Jan 23, 1998·Japanese Journal of Clinical Oncology·S Fujita, K Sugano
Oct 27, 1998·Pathology International·T FukudaT Nakamura
Apr 9, 1999·Nature Neuroscience·F Maina, R Klein
Sep 28, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Y W MoonZ Zhuang
Dec 20, 2000·The Journal of Clinical Investigation·T NakamuraT Nakamura
May 31, 2001·Kidney International·K Matsumoto, T Nakamura
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F RobertH W Waksal
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·D UchidaT Fujimori
Oct 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nikolaus SchieringCinzia Cristiani
Dec 20, 2003·Nature Reviews. Molecular Cell Biology·Carmen BirchmeierGeorge F Vande Woude
Mar 16, 2005·The American Journal of Surgical Pathology·Veli-Matti WaseniusHeikki Joensuu
Jan 7, 2006·Cancer Research·Monica Kong-BeltranRobert Yauch

❮ Previous
Next ❯

Citations

Feb 15, 2013·Current Oncology Reports·Theodore F Logan
Aug 8, 2012·Nature Reviews. Clinical Oncology·Cyrus Chargari, Eric Deutsch
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Zimmermann, S Peters
Dec 13, 2012·Journal of Translational Medicine·Giuseppina BonannoSergio Rutella
Feb 6, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefan Kasper, Martin Schuler
Apr 24, 2014·Future Oncology·Manjari Pandey, Daruka Mahadevan
Feb 14, 2014·International Journal of Radiation Oncology, Biology, Physics·Andrew M BaschnagelGeorge D Wilson
Sep 23, 2014·BMC Cancer·Daniel S W TanN Gopalakrishna Iyer
Jan 10, 2014·Cancer Metastasis Reviews·Jocelyn L Wozney, Emmanuel S Antonarakis
Jan 23, 2015·International Journal of Molecular Sciences·Daniele VergaraGian-Pietro Di Sansebastiano
Aug 12, 2014·International Journal of Molecular Sciences·Mohammad Hojjat-Farsangi
May 9, 2014·Expert Opinion on Investigational Drugs·Giuseppe AprileMario Scartozzi
Oct 13, 2014·Molecular Oncology·Viola BigattoCarla Boccaccio
Nov 6, 2013·Hematology/oncology Clinics of North America·Rana R McKayToni K Choueiri
Apr 16, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chao HanQuancheng Kan
Dec 4, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Jul 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·An Na SeoHye Seung Lee
Sep 29, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Pérez-RamírezMiguel Ángel Calleja-Hernández
Mar 12, 2015·Cancer Cell·Frederick H WilsonLevi A Garraway
Jun 10, 2015·Molecular Aspects of Medicine·Shuang Yin ZhangBassel F El-Rayes
Mar 14, 2013·European Journal of Clinical Investigation·Konstantinos KamposiorasNicholas Pavlidis
Sep 15, 2012·Pigment Cell & Melanoma Research·Brian J Nickoloff, George Vande Woude
Aug 21, 2013·European Journal of Haematology·Tobias Schmidt SlørdahlTorstein Baade Rø
Oct 10, 2013·The Journal of Pathology·Hartmut KoeppenRobert L Yauch
Feb 7, 2014·International Journal of Cancer. Journal International Du Cancer·Katia NonesSean M Grimmond
Sep 13, 2015·Drug Development Research·Zeynep F KaragonlarNeşe Atabey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.